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Bilateral ectopic pregnancy is a rare phenomenon which is found with increased frequency when using assisted reproductive
technology (ART). This diagnosis is most often made incidentally and intraoperatively, as ultrasound and serial 𝛽-hCG trends
have shown poor efficacy for accurate diagnosis. Management of bilateral ectopic pregnancies is most commonly reported using
bilateral surgical removal of the ectopic pregnancy (salpingostomy and/or salpingectomy). We present a case of an ART patient
with incidentally found bilateral tubal ectopic pregnancies, where multiple management strategies including medical and surgical
techniques were used concurrently which resulted in a subsequent spontaneous intrauterine pregnancy. While the standard of care
is difficult to establish, we recommend individualizing management decisions based on the patient’s reproductive goals and overall
risk profile.

1. Introduction
Unilateral ectopic pregnancy is a well-known and common
diagnosis in the general population [1]. Conversely, bilateral
ectopic pregnancy is a much rarer phenomenon, occurring
in approximately 1 per 200,000 live births [2]. While bilateral
ectopic pregnancies have been documented in the literature
since the 1900s, the invention of assisted reproductive technologies (ART) has led to an increase in reported cases of bilateral ectopic pregnancies [3, 4].
Given the relative frequency of bilateral ectopic pregnancies in the ART population, the importance of choosing
an appropriate management strategy is further underscored
given the known morbidity and potential mortality of ruptured ectopics within the context of the patient’s reproductive
goals. There are established criteria for management of
unilateral ectopic pregnancies, which include pharmacologic,
surgical, and expectant management under specific circumstances. However, there are no well-defined studies or data to
suggest standard of care in the case of bilateral tubal ectopic
pregnancies, particularly in the setting of one ruptured and
one nonruptured ectopic pregnancy. Upon review of the

existing literature, there are no reports of medical and surgical
management being used simultaneously for the management
of bilateral ectopic pregnancies, nor are there reports of a
subsequent spontaneous intrauterine pregnancy following
this treatment approach. Here we present a case of an
ART patient with incidentally found bilateral tubal ectopic
pregnancies, where two different management strategies were
used concurrently with a successful outcome.

2. Case Report
A 32-year-old G2P0020 healthy Caucasian female initially
presented to our institution for outpatient evaluation and
management of secondary infertility. Her obstetric history
was notable for two first-trimester miscarriages that were
both managed expectantly. The couple’s infertility evaluation revealed normal ovarian reserve testing and semenanalysis parameters with an unremarkable hysterosalpingogram (HSG) study, and they were diagnosed with unexplained infertility. The patient underwent ovulation induction with clomiphene citrate and HCG trigger with timed
intrauterine insemination (IUI) using her partner’s sperm. In

2

Case Reports in Obstetrics and Gynecology

Figure 1: TVUS image of right adnexa with corpus luteal cyst versus
ectopic gestation.

Figure 3: Left tubal ectopic pregnancy (active bleeding, treated with
salpingectomy).

Figure 2: TVUS image of left adnexa with embryonic structures
consistent with an ectopic pregnancy.

Figure 4: Right tubal ectopic pregnancy (treated with MTX).

the weeks following IUI, the 𝛽-hCG level rose appropriately
from 641 to 971 in 48 hours. One week later, the 𝛽-hCG
level rose to 3,448 and TVUS revealed a small, irregularly
shaped gestational sac in the uterus without a clear yolk sac
or evidence of a fetal pole. The right adnexa appeared to have
two corpus luteal cysts. Of note, no free fluid was identified in
the cul-de-sac and the patient was asymptomatic at that clinic
visit. The plan was for a repeat 𝛽-hCG level and TVUS in 48
hours.
The patient subsequently presented to the emergency
room the following morning with diffuse lower abdominal
pain and vaginal bleeding. TVUS identified what appeared
to be a corpus luteal cyst in the right ovary (Figure 1) and a
likely ectopic pregnancy in the left adnexa (Figure 2) with a
small amount of complex free fluid within the cul-de-sac. Her
abdominal exam was significant for involuntary guarding of
the lower quadrants bilaterally with diffuse tenderness. After
discussion with the patient regarding our concern for ruptured ectopic pregnancy, the patient was amenable with the
plan of proceeding with a laparoscopic unilateral salpingectomy.

A diagnostic laparoscopy was performed which revealed
moderate hemoperitoneum upon abdominal entry. On pelvic
survey, the left fallopian tube was noted to have a dilated distal
portion, approximately 2cm in diameter with active bleeding,
consistent with a ruptured left ectopic versus tubal abortion
(Figure 3). Notably, the mid-portion of the right fallopian
tube appeared dilated at the junction between the isthmus
and the ampulla, about 3cm in diameter, without evidence
of rupture or bleeding, which was concerning a concurrent
second ectopic pregnancy (Figure 4).
The surgeons were then faced with a difficult decision
regarding management of the unruptured contralateral tube.
The patient’s husband (and power of attorney) subsequently
became involved with all decisions regarding the patient’s
plan of care. A left salpingectomy was essential given the
abnormal left fallopian tube with active bleeding. Options
for management of the contralateral tube were presented:
right salpingectomy, right salpingostomy with Methotrexate
(MTX) administration, or MTX administration alone without surgical intervention on the right fallopian tube. After
thorough risk-benefit consideration, as well as intraoperative
consultation with the patient’s Reproductive Endocrinologist,
the decision was made to retain the right fallopian tube and
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proceed conservatively with MTX administration (singledose regimen of 50 mg/m2 ) due to the patient’s likely desire
to preserve her fallopian tube.
The patient had an uneventful recovery and her day 4
and day 7 𝛽-hCG values confirmed an appropriate decline
in 𝛽-hCG levels after MTX injection. The 𝛽-hCG level
had dropped to a nonpregnant level by approximately three
weeks following MTX administration. Histology of the left
fallopian tube included the presence of chorionic villi, which
confirmed the diagnosis of a left ectopic pregnancy. Repeat
TVUS one-month following the surgery was normal without
evidence of right tubal dilatation. Approximately 14 weeks
after surgery, the patient had a repeat TVUS which revealed
a single viable intrauterine pregnancy, which was conceived
spontaneously.

3. Discussion
The general incidence of single ectopic pregnancies varies
by study but according to the Center for Disease Control
and Prevention accounts for about 2% of pregnancies [5].
Despite improvements in early detection and management
modalities, ruptured ectopic pregnancies still account for a
significant percentage of pregnancy-related mortality. Evolving data suggests that conception from ART is an independent risk factor for the development of an ectopic gestation.
In literature review, studies describe a higher incidence of
ectopic pregnancies after various methods of ART, ranging
anywhere from 2.2 to 4.5% of ART cycles compared to spontaneous conception [6, 7]. In selected groups of patients with
tubal infertility, the incidence of ectopic pregnancies after
IVF may be as high as 11% [8]. A recent retrospective cohort
study published by the Zhengzhou Reproductive Medical
Center analyzed the incidence of ectopic pregnancies in
their IVF and IUI cycles over the preceding six years [9].
The overall ectopic rate was 3% in both subgroups, suggesting
an increased ectopic risk when comparing ART with spontaneous conception. Bilateral, or heterochronic, ectopics are the
rarest form of ectopic pregnancy. We have witnessed a 3-fold
increase in diagnosed bilateral ectopic pregnancies over the
past several decades, in part due to the increasing use of ART
technology [10].
When managing bilateral ectopic pregnancies, important
issues arise with regard to detection and treatment. Primarily,
trending the 𝛽-hCG values in bilateral ectopic pregnancies
has not been shown to be an effective diagnostic practice [11].
Additionally, in most published case reports on this topic,
early ultrasound use typically fails to make a diagnosis of
bilateral tubal involvement. In a review of 16 case reports on
bilateral ectopic pregnancies after ovulation induction, both
ectopic pregnancies were identified by ultrasound imaging
in only 6 of the cases prior to surgical intervention [12].
Accordingly, in a review by de los Rios et al. only 2 of 42
bilateral ectopic pregnancies were accurately diagnosed by
ultrasound [13]. Commonly, ultrasound imaging identifies
one ectopic pregnancy, which precipitates further investigation and subsequent management. Our case highlights this
discrepancy between ultrasound results and intraoperative
findings. Ultrasound may not be necessary to make the
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diagnosis, and patients with significant risk factors should be
counseled on the possibility of bilateral ectopic pregnancies,
and decisions regarding the management algorithm should
ideally be decided before surgery ensues. As a majority of
bilateral ectopic pregnancies are diagnosed intraoperatively,
inspection of both fallopian tubes should be standard of care
in any ectopic case where the patient has risk factors for multiple gestations.
Previous studies have suggested that the same options for
unilateral ectopic pregnancies be applied for bilateral ectopic
pregnancies, including MTX administration or laparoscopy
(with either salpingostomy or salpingectomy). However, due
to the rare nature of bilateral ectopic pregnancies, there are no
published guidelines to help advise management decisions.
Also, data is sparse with regard to fertility outcomes and
recurrent ectopic pregnancy rate after management of the
concurrent ectopic pregnancy. With regard to MTX administration for bilateral ectopic pregnancies, a previously published report described treatment failure using single-dose MTX
therapy, as the patient subsequently required surgery [14]. To
date, there are no published reports that describe effective
MTX dosage or regimen for bilateral ectopic pregnancies.
Bilateral ectopic pregnancies pose a unique dilemma in
that both tubes are likely damaged, increasing the risk of
future ectopic recurrence. As such, most cases of bilateral
ectopic pregnancies are treated with bilateral salpingectomy.
For instance, 12 of the 16 cases described by Zhu et al. involved
bilateral salpingectomy [12]. In our case, the power of attorney was counseled about potential reproductive options. It
was discussed that both fallopian tubes would likely have
underlying damage regardless of the chosen treatment option. Discussion continued where bilateral salpingectomies
would guarantee the need for IVF while a retained damaged
tube would increase the rate of recurrent ectopic pregnancy.
The only option that would maintain the possibility of spontaneous intrauterine pregnancy would be to retain the nonruptured tube and to treat medically or with salpingostomy.
However, with this approach, if ART was used the Reproductive Endocrinologist would likely recommend IVF in order to
decrease the risk of a repeat ectopic pregnancy. This complex
and rare situation emphasizes the importance of thorough
evaluation of treatment options while utilizing a patientcentric approach.
When deciding between salpingostomy and salpingectomy, it is important to consider the potential impact on
future fertility and subsequent ectopic pregnancy risk. RCTs
comparing the two techniques in unilateral ectopics have not
found significantly different rates for subsequent intrauterine
pregnancies or repeat ectopic pregnancies. However, cohort
studies have shown higher pregnancy rates for salpingostomy, including both intrauterine and ectopic rates [15].
Surgical management by bilateral salpingectomy should be
recommended for usual indication: the patient is exhibiting
hemodynamic instability or tubal bleeding. Salpingostomy or
MTX administration may be considered for the remaining
tube if IVF is not an option; however the patient should be
counseled on the recurrence risk and the possible need for
future surgery.
In the absence of established guidelines for the management of bilateral ectopic pregnancies, successful outcomes
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are required in order to help establish protocols for clinical
care. Our case presents a unique approach to the management
of the contralateral ectopic using medical therapy alone
without salpingostomy while already undergoing a surgical
procedure, which helped to preserve the remaining tube and
allow for spontaneous pregnancy. Complete treatment was
confirmed by a downtrend in the patient’s 𝛽-hCG level to a
nonpregnant level. Additionally, patients having a unilateral
salpingectomy with Methotrexate for the remaining ectopic
may consider performing a HSG remote from surgery in
order to determine residual tubal patency. One limitation of
our study is that tissue was not extracted from the second
fallopian tube; thus histologic confirmation of the second
ectopic pregnancy is not available.
In conclusion, we present a case of bilateral ectopic pregnancy which was successfully managed with unilateral salpingectomy and medical management with Methotrexate for
the contralateral ectopic. As the use of ART technique may
become increasingly more common, we may continue to witness a rising incidence of bilateral ectopic pregnancies. As
scarce data is published on this topic, it is essential to investigate innovative diagnostic and treatment modalities in order
to promote improved clinical care within this context.
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